ABL Bio Inc. — Investor Relations & Filings
ABL Bio Inc. is a clinical-stage biotechnology company specializing in the development of bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. The company leverages several proprietary platforms. For central nervous system disorders, its 'Grabody-B' technology is a blood-brain barrier (BBB) penetrating shuttle designed to enhance drug delivery to the brain. In immuno-oncology, ABL Bio develops 4-1BB based bispecific antibodies aimed at minimizing toxicity and overcoming resistance to existing immunotherapies. The company is also advancing a pipeline of antibody-drug conjugates (ADCs) with an improved therapeutic index for conditions such as rare blood cancers. ABL Bio actively progresses its therapeutic candidates through clinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2024.03) | 2024-05-14 | Korean | |
| [기재정정]주식등의대량보유상황보고서(일반) | 2024-04-05 | Korean | |
| 신규시설투자등 | 2024-04-05 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2024-04-05 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2024-04-02 | Korean | |
| 정기주주총회결과 | 2024-03-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8139193 | 분기보고서 (2024.03) | 2024-05-14 | Korean | ||
| 8149954 | [기재정정]주식등의대량보유상황보고서(일반) | 2024-04-05 | Korean | ||
| 8149947 | 신규시설투자등 | 2024-04-05 | Korean | ||
| 8149944 | 주식등의대량보유상황보고서(일반) | 2024-04-05 | Korean | ||
| 8151487 | 주식등의대량보유상황보고서(약식) | 2024-04-02 | Korean | ||
| 8153339 | 정기주주총회결과 | 2024-03-29 | Korean | ||
| 8153260 | 주식매수선택권부여에관한신고 | 2024-03-29 | Korean | ||
| 8173374 | 주식등의대량보유상황보고서(일반) | 2024-03-20 | Korean | ||
| 8184810 | 주주총회소집결의 (정기주주총회) | 2024-03-14 | Korean | ||
| 8184772 | 주주총회집중일개최사유신고 | 2024-03-14 | Korean | ||
| 8183092 | 사업보고서 (2023.12) | 2024-03-14 | Korean | ||
| 8182960 | 주주총회소집공고 | 2024-03-14 | Korean | ||
| 8182918 | 의결권대리행사권유참고서류 | 2024-03-14 | Korean | ||
| 8181577 | [기재정정]사업보고서 (2023.12) | 2024-03-14 | Korean | ||
| 8185541 | 감사보고서제출 | 2024-03-13 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
ABL Bio Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17558/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17558 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17558 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17558 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17558}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABL Bio Inc. (id: 17558)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.